BioSpace News Archive

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the second quarter ended June 30, 2022.

LYON, France, August3, 2022 - EDAP TMS SA, the global leader in robotic energy-based therapies, announced that it will release its financial results for the second quarter ended June 30th after the markets close on Wednesday, August 24th, 2022.

BioLife Sciences Inc. announced it has engaged GS Whitney & Co. to assist in building brand awareness, providing communications support and assisting in corporate relations.

Black Diamond Therapeutics, Inc. today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will participate in a panel discussion titled, Bullseye - Targeted Oncology - Quanta of Targets, at the Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022.

Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the addition of Matthew Kupferberg as the Company’s in-house General Counsel.

Journey Medical Corporation announced the Company will release its second quarter 2022 financial results after the U.S. financial markets close on Tuesday, August 9, 2022.

BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced that the Company’s management will participate in a fireside chat at the 2022 BTIG Biotechnology Conference, to be held in New York, NY Monday, August 8, 2022.

Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders, today announced the issuance of U.S. Patent No. 11,400,077.

2seventy bio, Inc . (Nasdaq: TSVT) announced today that members of the management team will participate in the following upcoming investor conferences.

Minerva Surgical, Inc. – The Uterine Health Company, focused on the treatment of Abnormal Uterine Bleeding, announced their Time To Talk social media campaign and local event series.